Skip to main content
    A

    Alpha Tau Medical Ltd (DRTS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $12.09
    +0.12 (+1.00%)

    Market Cap: $1.24B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Alpha Tau Medical Ltd (DRTS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Alpha Tau Medical (DRTS) has a market cap of $1.24B and an enterprise value of $1.22B. Its share count is up 13.05% from a year earlier.

    Total Valuation

    Enterprise value is 1.20% below the market cap, as cash exceeds debt.

    Market Cap$1.24B
    Enterprise Value$1.22B
    Latest price (Nov 17, 2026)$12.09

    Key Dates

    The next earnings report is expected on Nov 24, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 24, 2026 (expected)
    Last Earnings DateAug 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.39% in the quarter ended Jun 30, 2026 and grew 14.09% a year over 2 years.

    Shares Outstanding90.95M
    Shares Change (YoY)+13.05%
    Shares Change (QoQ)+1.39%
    Share Count Growth (2Y CAGR)+14.09%

    Price Statistics

    The stock is up 225.53% over 52 weeks and trades 13.33% below its 50-day average.

    Beta (1Y)2.14
    52-Week Change+225.53%
    1-Month Change-4.20%
    3-Month Change-16.45%
    6-Month Change+13.20%
    5-Year Change+31.52%
    Total Return (1Y)+225.53%
    Total Return (3Y CAGR)+58.25%
    Total Return (5Y CAGR)+4.06%
    Return vs SPY (1Y)+216.97%
    Max Drawdown (1Y)-23.87%
    Max Drawdown (3Y)-41.67%
    Sharpe Ratio (1Y)1.57
    Correlation with SPY (1Y)0.39
    50-Day Average$13.95
    200-Day Average$10.97
    52-Week Range$3.43 to $15.79
    RSI (14 Days)38.2
    Average Volume (20 Days)609.31K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 11.09x current liabilities, and total debt is 0.18x shareholder equity.

    Current Ratio11.09x
    Quick Ratio11.09x
    Debt / Equity0.18x

    Returns and Efficiency

    Return on invested capital is -176.93% over the last 12 months, against a 5-year average of -23.57%.

    Return on Equity (ROE)-210.13%
    Return on Assets (ROA)-68.96%
    Return on Invested Capital (ROIC)-176.93%
    Return on Capital Employed (ROCE)-74.08%
    ROIC (5Y Average)-23.57%

    Scores

    DRTS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$50.43M
    Pretax Income-$92.40M
    Net Income-$92.57M
    EBITDA-$49.07M
    EBIT-$92.31M
    Reported EPS (TTM)-$1.04

    Trailing 12 months through Jun 30, 2026.

    Balance Sheet

    Shareholder equity funds 32.81% of the $134.25M in total assets.

    Cash and Equivalents$22.99M
    Total Debt$8.12M
    Net Cash$14.87M
    Net Cash Per Share$0.16
    Working Capital$97.20M
    Shareholder Equity$44.05M
    Book Value Per Share$0.48
    Total Assets$134.25M
    Total Liabilities$90.19M

    Balance sheet as of Jun 30, 2026.

    Cash Flow

    Capital Expenditures$6.08M
    FCF Per Share-$0.42

    Trailing 12 months through Jun 30, 2026.

    Growth

    Book Value Per Share Growth (2Y CAGR)-13.85%
    Tangible Book Per Share Growth (2Y CAGR)-13.85%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DRTS

    What is DRTS's market cap?

    Alpha Tau Medical has a market cap of $1.24B. Its enterprise value, which adds debt and subtracts cash, is $1.22B.

    How many shares of DRTS are outstanding?

    Alpha Tau Medical has 90.95M shares outstanding. The count is up 13.05% from a year earlier.

    Does DRTS pay a dividend?

    No. Alpha Tau Medical does not pay a dividend.

    How much debt does DRTS have?

    Alpha Tau Medical has $8.12M of total debt and $22.99M of cash and equivalents, a net cash position of $14.87M.